These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 36345412)

  • 41. Challenges in Laboratory Diagnosis of the Novel Coronavirus SARS-CoV-2.
    Younes N; Al-Sadeq DW; Al-Jighefee H; Younes S; Al-Jamal O; Daas HI; Yassine HM; Nasrallah GK
    Viruses; 2020 May; 12(6):. PubMed ID: 32466458
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Application of nanodiagnostics in point-of-care tests for infectious diseases.
    Wang Y; Yu L; Kong X; Sun L
    Int J Nanomedicine; 2017; 12():4789-4803. PubMed ID: 28740385
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Miniaturized Real-Time PCR systems for SARS-CoV-2 detection at the Point-of-Care.
    Garzarelli V; Chiriacò MS; Cereda M; Autuori I; Ferrara F
    Clin Chim Acta; 2022 Nov; 536():104-111. PubMed ID: 36126763
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A systematic review of the advancement on colorimetric nanobiosensors for SARS-CoV-2 detection.
    Tessaro L; Aquino A; Panzenhagen P; Joshi N; Conte-Junior CA
    J Pharm Biomed Anal; 2023 Jan; 222():115087. PubMed ID: 36206693
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Diagnostic assay and technology advancement for detecting SARS-CoV-2 infections causing the COVID-19 pandemic.
    Dhar BC
    Anal Bioanal Chem; 2022 Apr; 414(9):2903-2934. PubMed ID: 35211785
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Innovations and Challenges in Electroanalytical Tools for Rapid Biosurveillance of SARS-CoV-2.
    Ardalan S; Ignaszak A
    Adv Mater Technol; 2022 Jun; ():2200208. PubMed ID: 35942251
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Paper-Based Biosensors for COVID-19: A Review of Innovative Tools for Controlling the Pandemic.
    Pinheiro T; Cardoso AR; Sousa CEA; Marques AC; Tavares APM; Matos AM; Cruz MT; Moreira FTC; Martins R; Fortunato E; Sales MGF
    ACS Omega; 2021 Nov; 6(44):29268-29290. PubMed ID: 34778604
    [TBL] [Abstract][Full Text] [Related]  

  • 48. PCR past, present and future.
    Zhu H; Zhang H; Xu Y; Laššáková S; Korabečná M; Neužil P
    Biotechniques; 2020 Oct; 69(4):317-325. PubMed ID: 32815744
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Coronavirus: a comparative analysis of detection technologies in the wake of emerging variants.
    Sharma S; Shrivastava S; Kausley SB; Rai B; Pandit AB
    Infection; 2023 Feb; 51(1):1-19. PubMed ID: 35471631
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Point of Care Diagnostics in the Age of COVID-19.
    Rezaei M; Razavi Bazaz S; Zhand S; Sayyadi N; Jin D; Stewart MP; Ebrahimi Warkiani M
    Diagnostics (Basel); 2020 Dec; 11(1):. PubMed ID: 33374612
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Biotechnological Perspectives to Combat the COVID-19 Pandemic: Precise Diagnostics and Inevitable Vaccine Paradigms.
    Aileni M; Rohela GK; Jogam P; Soujanya S; Zhang B
    Cells; 2022 Mar; 11(7):. PubMed ID: 35406746
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Review of Current COVID-19 Diagnostics and Opportunities for Further Development.
    Mardian Y; Kosasih H; Karyana M; Neal A; Lau CY
    Front Med (Lausanne); 2021; 8():615099. PubMed ID: 34026773
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Emerging trends in point-of-care biosensing strategies for molecular architectures and antibodies of SARS-CoV-2.
    Karuppaiah G; Vashist A; Nair M; Veerapandian M; Manickam P
    Biosens Bioelectron X; 2023 May; 13():100324. PubMed ID: 36844889
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Micro and Nanoscale Technologies for Diagnosis of Viral Infections.
    Nasrollahi F; Haghniaz R; Hosseini V; Davoodi E; Mahmoodi M; Karamikamkar S; Darabi MA; Zhu Y; Lee J; Diltemiz SE; Montazerian H; Sangabathuni S; Tavafoghi M; Jucaud V; Sun W; Kim HJ; Ahadian S; Khademhosseini A
    Small; 2021 Nov; 17(45):e2100692. PubMed ID: 34310048
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Advances in point-of-care technologies for molecular diagnostics.
    Zarei M
    Biosens Bioelectron; 2017 Dec; 98():494-506. PubMed ID: 28728010
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Role and implications of nanodiagnostics in the changing trends of clinical diagnosis.
    Alharbi KK; Al-Sheikh YA
    Saudi J Biol Sci; 2014 Apr; 21(2):109-17. PubMed ID: 24600302
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Application of Nanobiotechnology for Early Diagnosis of SARS-CoV-2 Infection in the COVID-19 Pandemic.
    Sheervalilou R; Shirvaliloo M; Sargazi S; Shirvalilou S; Shahraki O; Pilehvar-Soltanahmadi Y; Sarhadi A; Nazarlou Z; Ghaznavi H; Khoei S
    Appl Microbiol Biotechnol; 2021 Apr; 105(7):2615-2624. PubMed ID: 33710356
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Paper-Based Point-of-Care Testing of SARS-CoV-2.
    Jia Y; Sun H; Tian J; Song Q; Zhang W
    Front Bioeng Biotechnol; 2021; 9():773304. PubMed ID: 34912791
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection.
    Dinnes J; Deeks JJ; Berhane S; Taylor M; Adriano A; Davenport C; Dittrich S; Emperador D; Takwoingi Y; Cunningham J; Beese S; Domen J; Dretzke J; Ferrante di Ruffano L; Harris IM; Price MJ; Taylor-Phillips S; Hooft L; Leeflang MM; McInnes MD; Spijker R; Van den Bruel A;
    Cochrane Database Syst Rev; 2021 Mar; 3(3):CD013705. PubMed ID: 33760236
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.